Variations in end‐of‐life care practices in older critically ill patients with COVID‐19 in Europe

Abstract

Background Previous studies reported regional differences in end‐of‐life care (EoLC) for critically ill patients in Europe. Objectives The purpose of this post‐hoc analysis of the prospective multicentre COVIP study was to investigate variations in EoLC practices among older patients in intensive care units during the coronavirus disease 2019 pandemic. Methods A total of 3105 critically ill patients aged 70 years and older were enrolled in this study (Central Europe: n = 1573; Northern Europe: n = 821; Southern Europe: n = 711). Generalised estimation equations were used to calculate adjusted odds ratios (aORs) to population averages. Data were adjusted for patient‐specific variables (demographic, disease‐specific) and health economic data (gross domestic product, health expenditure per capita). The primary outcome was any treatment limitation, and 90‐day mortality was a secondary outcome. Results The frequency of the primary endpoint (treatment limitation) was highest in Northern Europe (48%), intermediate in Central Europe (39%) and lowest in Southern Europe (24%). The likelihood for treatment limitations was lower in Southern than in Central Europe (aOR 0.39; 95% confidence interval [CI] 0.21–0.73; p = 0.004), even after multivariable adjustment, whereas no statistically significant differences were observed between Northern and Central Europe (aOR 0.57; 95%CI 0.27–1.22; p = 0.15). After multivariable adjustment, no statistically relevant mortality differences were found between Northern and Central Europe (aOR 1.29; 95%CI 0.80–2.09; p = 0.30) or between Southern and Central Europe (aOR 1.07; 95%CI 0.66–1.73; p = 0.78). Conclusion This study shows a north‐to‐south gradient in rates of treatment limitation in Europe, highlighting the heterogeneity of EoLC practices across countries. However, mortality rates were not affected by these results.

Predictors of outcomes of patients ≥ 80 years old admitted to intensive care units in Poland – a post-hoc analysis of the VIP2 prospective observational study

“…There is a significant variance in applying treatment limitations to elderly patients in ICUs across Europe. One study of COVID-19 patients identified a “North to South Gradient” in treatment limitations, with Northern European countries having the highest propensity to limit life-sustaining treatment and Southern European countries being characterised by the lowest rate of treatment limitations [ 29 ]. Numerous factors have been postulated as contributors to treatment limitation variability, including state legislation [ 30 ], religion [ 31 ], and cultural factors [ 31 ].…”

Clinical Frailty Scale - frailty assessment and rehabilitation potential

“…This expanded role positions the CFS as a valuable instrument for facilitating the development of risk-adjusted, patient-centered care plans for this at-risk population. [23] Research suggests a potential link between the severity of dementia and the degree of frailty in older adults. Milder forms of dementia might present alongside milder frailty, while more severe stages of both conditions often appear together.…”

Long-term temporal trends in incidence rate and case fatality of sepsis and COVID-19-related sepsis in Norwegian hospitals, 2008–2021: a nationwide registry study

“…Moreover, our study could only identify one-fourth of the reported deaths due to COVID-19 in Norway at the end of 2021, which suggest that the majority of deaths due to COVID-19 occurred outside the hospitals. A possible explanation for the low proportion of in-hospital deaths due to COVID-19-related sepsis could be a higher threshold for hospitalisation during the pandemic in order to avoid an overflow of ill patients to hospitals 40…”